Global Endometrial Cancer Therapeutics Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 2023 – Market Research Report 2017 has published new research report on "Global Endometrial Cancer Therapeutics Market Research Report and Forecast to 2017-2023" to its database.

Dallas, United States - July 17, 2017 /MarketersMedia/ —

Endometrial Carcinoma is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, endometrial cancer is also the most common cancer of the female reproductive organs in the US. About 60,050 new cases of cancer of uterus were estimated to be diagnosed during 2016, and about 10,470 women died from cancers of the uterine body during the same year.Early detection of endometrial cancer helps in the selection of proper treatment options. Endometrial Cancer can be treated by one or combination of therapies, such as chemotherapy, radiation therapy, hormone therapy, and surgery. Most of the physicians generally recommend combination treatments because chemotherapy alone has conventionally been deemed ineffective. Furthermore, adjuvant radiation therapy is ideal in patients who have diagnosed with Stage I or II endometrial cancer. Radiation Therapy is also recommended in patients who have undergone the surgery to avoid the relapse of endometrial cancer.

Browse the report:

According to the RNCOS report entitled “Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023”, the Endometrial Cancer therapeutics market is poised to reach approximately US$ 27 Billion by 2023. In this report, there is in-depthmarket analysis as well as market segmentation of global endometrial cancer therapeutics. The market potential of endometrial cancer therapeutic drugsisestimated considering that these are being tested in clinical trials for endometrial cancer, besides the ones which have already been approved. The depictedendometrial cancer therapeutic drugsare expected to show their complete market potential soon in the coming years.

Furthermore, in this report we have structured the information on epidemiology of endometrial cancer in the world. The report also covers pipeline analysis of endometrial cancer therapeutic drugs at various stages of clinical development that are under research or in collaboration, and those individually being developed by companies. Moreover, our report places an emphasis on the major drivers and challenges, latest trends and developments,as well as strategic collaborations that can impact industry’s growth.

Request a sample of the report:

In the end, the report enlists some of the key players in the Endometrial Cancer Therapeutics market including business overview of each player along with their product and pipeline portfolios, recent developments, and comparative analysis of their strengths and weaknesses.Conclusively, the report will prove to be a complete and comprehensive source of knowledge and analysis for clients and potential investors or debut makers in this industry.

Major Points From The Table Of Contents:
Analyst View
Research Methodology
Endometrial Cancer - Epidemiology & Risk Factors
Endometrial Cancer Therapeutics - An Introduction
Market Dynamics
Endometrial Cancer Therapeutics Market Outlook to 2023
Market Segmentation
Endometrial Cancer Therapeutic Drugs Pipeline Analysis
Trends and Developments
Strategic Mergers & Collaborations in the Endometrial Cancer Therapeutics Industry
Competitive Assessment

Buy the report@

List of Figures:
Figure 3-1: Estimated Age-specific Incidence & Mortality Rates for Endometrial Cancer, 2016
Figure 4-1: Endometrial Cancer Therapeutic Drugs - Mechanism of Action
Figure 5-1: Global Healthcare Spending (Billion US$), 2015 & 2020
Figure 5-2: Healthcare Spending by Region (Billion US$), 2015 & 2020
Figure 6-1: Global - Endometrial Cancer Therapeutics Market (Billion US$), 2016-2023
Figure 7-1: Global - Endometrial Cancer Therapeutics Market by Therapy (%), 2016
Figure 7-2: Global - Endometrial Cancer Chemotherapy Market (Billion US$), 2016 & 2023
Figure 7-3: Global - Endometrial Cancer Hormone Therapy Market (Billion US$), 2016 & 2023
Figure 7-4: Global - Endometrial Cancer Radiation Therapy Market (Billion US$), 2016 & 2023
Figure 7-5: Global - Endometrial Cancer Surgery Market (Billion US$), 2016 & 2023
Figure 7-6: Global - Endometrial Cancer Therapeutics Market by End Users (%), 2016
Figure 7-7: Global - Endometrial Cancer Therapeutics Market by Research Institutes (Billion US$), 2016 & 2023
Figure 7-8: Global - Endometrial Cancer Therapeutics Market by Hospitals (Billion US$), 2016 & 2023

List of Tables:
Table 6-1: Potential Patients for Endometrial Cancer Therapeutics, 2015, 2020 & 2025
Table 8-1: Industrial Endometrial Cancer Therapeutic Drugs Pipeline
Table 8-2: Research Collaborations Endometrial Cancer Therapeutic Drugs Pipeline
Table 10-1: Strategic Mergers & Collaborations in Endometrial Cancer Therapeutics Industry, 2014-2016
Table 11-1: Top Companies by Endometrial Cancer Therapeutic Drugs in Pipeline (2016)
Table 11-2: Bayer AG - Endometrial Cancer Therapeutic Drugs in Pipeline
Table 11-3: Bayer AG - Key Financials (Million US$), 2014-2016
Table 11-4: F. Hoffman La Roche Ltd. - Endometrial Cancer Therapeutic Drugs in Pipeline
Table 11-5: F. Hoffman La Roche Ltd. - Key Financials (Million US$), 2014-2016

About Us:
Orbis Research ( is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817

Source URL:

For more information, please visit

Source: MarketersMedia

Release ID: 217971

Latest News

Space capsule with 3 astronauts returns to Earth

Dec 14, 2017

MOSCOW — Three astronauts on Thursday landed back on Earth after nearly six months aboard the International Space Station. A Russian Soyuz capsule with NASA's Randy Bresnik, Russia's Sergey Ryazanskiy and Paolo Nespoli of the European Space Agency descended under a red-and-white parachute and landed on schedule at 2:37 p.m. local time (0837 GMT; 3:37 a.m. EST) on the vast steppes outside of a remote town in Kazakhstan. The three were extracted from the capsule within 20 minutes and appeared to be in good condition. Bresnik, Ryazansky and Nespoli spent 139 days aboard the orbiting space laboratory. The trio who...

Study: Loss of water in drought caused Sierra Nevada to rise

Dec 14, 2017

LOS ANGELES — Loss of water from rocks during drought caused California's Sierra Nevada to rise nearly an inch (2.5 centimeters) in height from October 2011 to October 2015, according to a new NASA study made public Wednesday. The study also found that in the following two years of increased snow and rain, the rocks in the range regained about half as much water as was lost during the drought and the return of the weight caused the height of the mountains to fall about half an inch (1.3 centimeters). "This suggests that the solid Earth has a greater capacity...

'Mannequin Skywalker' rides Blue Origin's new crew capsule

Dec 14, 2017

CAPE CANAVERAL, Fla. — Blue Origin's 'Mannequin Skywalker' has rocketed almost all the way to space, just in time for the new Star Wars movie. The aerospace company led by Amazon's Jeff Bezos launched its New Shepard rocket Tuesday from West Texas for the seventh time. It marked the first flight, though, of the latest version of Blue Origin's crew capsule, featuring big windows for future space tourists. An instrumented test dummy was aboard, named Mannequin Skywalker and dressed in a blue — naturally — flight suit. "He had a great ride," Bezos said via Twitter. The New Shepard rocket,...

Monkey selfies, eclipse, bitcoin, Lauer top Google in 2017

Dec 14, 2017

SAN FRANCISCO — Matt Lauer. Bitcoin. DACA. Monkey selfies. Jeremy Lin's hair. Do-it-yourself eclipse glasses. Tom Petty's death. National anthem protests in the NFL. And "Cash Me Outside." These were some of the people, topics and memes that trended to the top of Google searches in 2017. The search terms reflected the United States in upheaval over sexual misconduct allegations against powerful men, reeling from the tumultuous presidency of Donald Trump (What is "covfefe," by the way?), and people around the world searching for information about the latest iPhone and how to make slime. Three of the top 10 TV...

SpaceX delivery delayed few days; 1st reused rocket for NASA

Dec 14, 2017

CAPE CANAVERAL, Fla. — SpaceX has delayed its latest grocery run for the International Space Station by at least another few days. The company now aims to launch its first recycled rocket for NASA on Friday. The unmanned Falcon rocket originally flew in June. The Dragon capsule made a space station shipment in 2015. This will be the first launch in more than a year from this Florida pad, the scene of a rocket explosion in 2016. Late Tuesday, SpaceX pushed back the launch for the second day in a row, saying it needs to rid the second-stage fuel system...


Recent Discovery will take you to the captivating developments in science, technology, and the universe around us. We deliver to you the latest news, theories, and developments in the world of science.

Contact us:

Trending News

ScienceAgricultural ScienceArchaeologyAstronomy Press